In addition, cancer-specific survival was also higher in patients with HLA-I positive/PD-L1 negative tumors (p = 0.039) and even more significant in double positive tumors (p = 0.019) when compared to the tumors with immune escape phenotype HLA-I negative/PD-L1 positive (Figure S1). This evidence concerns the gene CD274 and cancer.